Keli Walbert Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

APLS Quotes by TradingView

Keli Walbert is Director of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 17,051 shares of APLS, which is worth approximately $346,646. The most recent transaction as insider was on Jan 01, 2026, when has been sold 7,961 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.1K
87.58% 3M change
87.58% 12M change
Total Value Held $346,646

Keli Walbert Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 01 2026
BUY
Grant, award, or other acquisition
-
7,961 Added 31.83%
17,051 Common Stock
Jan 08 2025
BUY
Grant, award, or other acquisition
-
9,090 Added 50.0%
9,090 Common Stock

Also insider at

SPRB
SPRUCE BIOSCIENCES, INC. Healthcare
KW

Keli Walbert

Director
Waltham, MA

Track Institutional and Insider Activities on APLS

Follow Apellis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

News

Receive news related to Apellis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APLS